International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.08 and traded as high as $0.12. International Stem Cell shares last traded at $0.12, with a volume of 5,682 shares trading hands.
International Stem Cell Stock Performance
The company’s 50-day simple moving average is $0.09 and its two-hundred day simple moving average is $0.08. The firm has a market cap of $960,000.00, a PE ratio of -1.50 and a beta of 0.21.
International Stem Cell Company Profile
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Further Reading
- Five stocks we like better than International Stem Cell
- Investing in the High PE Growth Stocks
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- When to Sell a Stock for Profit or Loss
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
